Complications After Surgical Management of Proximal Femoral Metastasis: A Retrospective Study of 417 Patients.
Janssen SJ et al. J Am Acad Orthop Surg. 2016 May 25. [Epub ahead of print].

Renal impairment in multiple myeloma: A single center experience.
Gorsane I et al. Saudi J Kidney Dis Transpl. 2016 May-Jun;27(3):480-5. doi: 10.4103/1319-2442.182380.

A review of the Venous Thrombotic Issues associated with Multiple Myeloma.
Fotiou D et al. Expert Rev Hematol. 2016 May 27. [Epub ahead of print].

Lymphomatoid papulosis associated with multiple myeloma.
Lee YJ et al. Int J Dermatol. 2016 May 27. doi: 10.1111/ijd.13286. [Epub ahead of print].

Identification of Risk Factors for Bisphosphonate-Associated Atypical Femoral Fractures and Osteonecrosis of the Jaw in a Pharmacovigilance Database.
Bejhed RS et al. Ann Pharmacother. 2016 May 13. pii: 1060028016649368. [Epub ahead of print].

Immune thrombocytopenia purpura associated with multiple myeloma.
Faller E et al. Ann Hematol. 2016 May 13. [Epub ahead of print].

Corneal Structural Changes in Nonneoplastic and Neoplastic Monoclonal Gammopathies.
Aragona P et al. Invest Ophthalmol Vis Sci. 2016 May 1;57(6):2657-65. doi: 10.1167/iovs.15-18594.

A rare case of listeriosis, acute cholecystitis and multiple myeloma.
Polanco TO et al. J Surg Case Rep. 2016 May 11;2016(5). pii: rjw080. doi: 10.1093/jscr/rjw080.

An international, multicenter, prospective, observational study of neutropenia in patients being treated with lenalidomide + dexamethasone for relapsed or relapsed/refractory multiple myeloma (RR-MM).
Leleu X et al. Am J Hematol. 2016 May 11. doi: 10.1002/ajh.24416. [Epub ahead of print].

Severe clavicular disease in multiple myeloma.
Ferretti A et al. Br J Haematol. 2016 May 10. doi: 10.1111/bjh.14108. [Epub ahead of print].

Echocardiography-Defined Pulmonary Hypertension in Multiple Myeloma: Risk Factors and Impact on Outcomes.
Sangani RG et al. South Med J. 2016 May;109(5):282-9. doi: 10.14423/SMJ.0000000000000461.

Evaluation of the risk factors associated with high-dose chemotherapy-induced dysgeusia in patients undergoing autologous hematopoietic stem cell transplantation: possible usefulness of cryotherapy in dysgeusia prevention.
Okada N et al. Support Care Cancer. 2016 Apr 29. [Epub ahead of print].